nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C19—coronary artery disease	0.196	1	CbGaD
Levomilnacipran—CYP2C8—Fenofibrate—coronary artery disease	0.0268	0.0487	CbGbCtD
Levomilnacipran—CYP2C8—Gemfibrozil—coronary artery disease	0.0214	0.0389	CbGbCtD
Levomilnacipran—ABCB1—Ticagrelor—coronary artery disease	0.0203	0.037	CbGbCtD
Levomilnacipran—CYP2C8—Clopidogrel—coronary artery disease	0.0186	0.0337	CbGbCtD
Levomilnacipran—CYP2C19—Gemfibrozil—coronary artery disease	0.018	0.0326	CbGbCtD
Levomilnacipran—CYP2C8—Pitavastatin—coronary artery disease	0.0162	0.0295	CbGbCtD
Levomilnacipran—CYP2C19—Clopidogrel—coronary artery disease	0.0156	0.0283	CbGbCtD
Levomilnacipran—CYP2C19—Telmisartan—coronary artery disease	0.0136	0.0247	CbGbCtD
Levomilnacipran—ABCB1—Clopidogrel—coronary artery disease	0.0126	0.0228	CbGbCtD
Levomilnacipran—ABCB1—Perindopril—coronary artery disease	0.0126	0.0228	CbGbCtD
Levomilnacipran—CYP3A4—Ticagrelor—coronary artery disease	0.0122	0.0222	CbGbCtD
Levomilnacipran—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0117	0.0212	CbGbCtD
Levomilnacipran—CYP2C8—Simvastatin—coronary artery disease	0.0111	0.0202	CbGbCtD
Levomilnacipran—ABCB1—Pitavastatin—coronary artery disease	0.011	0.02	CbGbCtD
Levomilnacipran—ABCB1—Telmisartan—coronary artery disease	0.011	0.02	CbGbCtD
Levomilnacipran—CYP2C19—Timolol—coronary artery disease	0.011	0.0199	CbGbCtD
Levomilnacipran—CYP2C8—Pravastatin—coronary artery disease	0.0109	0.0198	CbGbCtD
Levomilnacipran—CYP2C8—Lovastatin—coronary artery disease	0.0109	0.0198	CbGbCtD
Levomilnacipran—CYP3A4—Fenofibrate—coronary artery disease	0.0109	0.0197	CbGbCtD
Levomilnacipran—ABCB1—Enalapril—coronary artery disease	0.0104	0.0189	CbGbCtD
Levomilnacipran—ABCB1—Lisinopril—coronary artery disease	0.0104	0.0189	CbGbCtD
Levomilnacipran—CYP2C19—Rosuvastatin—coronary artery disease	0.01	0.0182	CbGbCtD
Levomilnacipran—CYP2C8—Atorvastatin—coronary artery disease	0.00991	0.018	CbGbCtD
Levomilnacipran—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00978	0.0178	CbGbCtD
Levomilnacipran—CYP2C19—Simvastatin—coronary artery disease	0.00933	0.017	CbGbCtD
Levomilnacipran—CYP2C19—Lovastatin—coronary artery disease	0.00913	0.0166	CbGbCtD
Levomilnacipran—CYP2C8—Losartan—coronary artery disease	0.00907	0.0165	CbGbCtD
Levomilnacipran—CYP2D6—Niacin—coronary artery disease	0.00897	0.0163	CbGbCtD
Levomilnacipran—ABCB1—Timolol—coronary artery disease	0.00885	0.0161	CbGbCtD
Levomilnacipran—CYP3A4—Gemfibrozil—coronary artery disease	0.00868	0.0158	CbGbCtD
Levomilnacipran—CYP2D6—Timolol—coronary artery disease	0.00834	0.0152	CbGbCtD
Levomilnacipran—CYP2C19—Atorvastatin—coronary artery disease	0.00832	0.0151	CbGbCtD
Levomilnacipran—ABCB1—Ezetimibe—coronary artery disease	0.0081	0.0147	CbGbCtD
Levomilnacipran—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00789	0.0143	CbGbCtD
Levomilnacipran—ABCB1—Captopril—coronary artery disease	0.00779	0.0142	CbGbCtD
Levomilnacipran—CYP2C19—Losartan—coronary artery disease	0.00761	0.0138	CbGbCtD
Levomilnacipran—CYP3A4—Clopidogrel—coronary artery disease	0.00753	0.0137	CbGbCtD
Levomilnacipran—ABCB1—Simvastatin—coronary artery disease	0.00753	0.0137	CbGbCtD
Levomilnacipran—ABCB1—Lovastatin—coronary artery disease	0.00737	0.0134	CbGbCtD
Levomilnacipran—ABCB1—Pravastatin—coronary artery disease	0.00737	0.0134	CbGbCtD
Levomilnacipran—CYP2D6—Captopril—coronary artery disease	0.00734	0.0133	CbGbCtD
Levomilnacipran—CYP2D6—Simvastatin—coronary artery disease	0.00709	0.0129	CbGbCtD
Levomilnacipran—CYP3A4—Eplerenone—coronary artery disease	0.007	0.0127	CbGbCtD
Levomilnacipran—CYP2D6—Pravastatin—coronary artery disease	0.00694	0.0126	CbGbCtD
Levomilnacipran—CYP2D6—Lovastatin—coronary artery disease	0.00694	0.0126	CbGbCtD
Levomilnacipran—ABCB1—Atorvastatin—coronary artery disease	0.00671	0.0122	CbGbCtD
Levomilnacipran—CYP2D6—Atorvastatin—coronary artery disease	0.00632	0.0115	CbGbCtD
Levomilnacipran—CYP3A4—Enalapril—coronary artery disease	0.00624	0.0113	CbGbCtD
Levomilnacipran—ABCB1—Losartan—coronary artery disease	0.00614	0.0112	CbGbCtD
Levomilnacipran—CYP3A4—Ezetimibe—coronary artery disease	0.00485	0.00882	CbGbCtD
Levomilnacipran—CYP3A4—Rosuvastatin—coronary artery disease	0.00485	0.00882	CbGbCtD
Levomilnacipran—CYP3A4—Simvastatin—coronary artery disease	0.00451	0.0082	CbGbCtD
Levomilnacipran—CYP3A4—Pravastatin—coronary artery disease	0.00441	0.00802	CbGbCtD
Levomilnacipran—CYP3A4—Lovastatin—coronary artery disease	0.00441	0.00802	CbGbCtD
Levomilnacipran—CYP3A4—Atorvastatin—coronary artery disease	0.00402	0.00731	CbGbCtD
Levomilnacipran—CYP3A4—Losartan—coronary artery disease	0.00368	0.00668	CbGbCtD
Levomilnacipran—SLC6A2—sympathetic nervous system—coronary artery disease	0.00236	0.211	CbGeAlD
Levomilnacipran—CYP2J2—artery—coronary artery disease	0.00189	0.169	CbGeAlD
Levomilnacipran—SLC6A2—autonomic nervous system—coronary artery disease	0.00159	0.142	CbGeAlD
Levomilnacipran—CYP2J2—cardiac ventricle—coronary artery disease	0.00106	0.0949	CbGeAlD
Levomilnacipran—CYP2J2—myocardium—coronary artery disease	0.001	0.0893	CbGeAlD
Levomilnacipran—CYP2J2—heart—coronary artery disease	0.000698	0.0623	CbGeAlD
Levomilnacipran—CYP2J2—cardiovascular system—coronary artery disease	0.000658	0.0588	CbGeAlD
Levomilnacipran—CYP2J2—cardiac atrium—coronary artery disease	0.000597	0.0533	CbGeAlD
Levomilnacipran—SLC6A4—blood—coronary artery disease	0.000281	0.0251	CbGeAlD
Levomilnacipran—CYP2C19—blood—coronary artery disease	0.000233	0.0208	CbGeAlD
Levomilnacipran—CYP2C8—blood—coronary artery disease	0.000203	0.0181	CbGeAlD
Levomilnacipran—CYP3A4—blood—coronary artery disease	0.000138	0.0123	CbGeAlD
Levomilnacipran—CYP2D6—blood—coronary artery disease	0.000135	0.0121	CbGeAlD
Levomilnacipran—ABCB1—heart—coronary artery disease	0.00013	0.0117	CbGeAlD
Levomilnacipran—ABCB1—cardiovascular system—coronary artery disease	0.000123	0.011	CbGeAlD
Levomilnacipran—ABCB1—blood—coronary artery disease	9.73e-05	0.0087	CbGeAlD
Levomilnacipran—Hypersensitivity—Niacin—coronary artery disease	7.35e-05	0.000415	CcSEcCtD
Levomilnacipran—Asthenia—Olmesartan—coronary artery disease	7.33e-05	0.000414	CcSEcCtD
Levomilnacipran—Headache—Clopidogrel—coronary artery disease	7.33e-05	0.000414	CcSEcCtD
Levomilnacipran—Rash—Lovastatin—coronary artery disease	7.33e-05	0.000413	CcSEcCtD
Levomilnacipran—Dermatitis—Lovastatin—coronary artery disease	7.32e-05	0.000413	CcSEcCtD
Levomilnacipran—Dyspepsia—Losartan—coronary artery disease	7.31e-05	0.000412	CcSEcCtD
Levomilnacipran—Headache—Lovastatin—coronary artery disease	7.28e-05	0.000411	CcSEcCtD
Levomilnacipran—Pruritus—Valsartan—coronary artery disease	7.26e-05	0.00041	CcSEcCtD
Levomilnacipran—Dry mouth—Ramipril—coronary artery disease	7.26e-05	0.00041	CcSEcCtD
Levomilnacipran—Chest pain—Timolol—coronary artery disease	7.26e-05	0.00041	CcSEcCtD
Levomilnacipran—Vomiting—Ezetimibe—coronary artery disease	7.25e-05	0.000409	CcSEcCtD
Levomilnacipran—Hypersensitivity—Pravastatin—coronary artery disease	7.24e-05	0.000409	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Perindopril—coronary artery disease	7.24e-05	0.000408	CcSEcCtD
Levomilnacipran—Anxiety—Timolol—coronary artery disease	7.24e-05	0.000408	CcSEcCtD
Levomilnacipran—Pruritus—Olmesartan—coronary artery disease	7.23e-05	0.000408	CcSEcCtD
Levomilnacipran—Decreased appetite—Losartan—coronary artery disease	7.22e-05	0.000407	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.21e-05	0.000407	CcSEcCtD
Levomilnacipran—Body temperature increased—Captopril—coronary artery disease	7.21e-05	0.000407	CcSEcCtD
Levomilnacipran—Abdominal pain—Captopril—coronary artery disease	7.21e-05	0.000407	CcSEcCtD
Levomilnacipran—Dizziness—Simvastatin—coronary artery disease	7.19e-05	0.000406	CcSEcCtD
Levomilnacipran—Rash—Ezetimibe—coronary artery disease	7.19e-05	0.000406	CcSEcCtD
Levomilnacipran—Dermatitis—Ezetimibe—coronary artery disease	7.18e-05	0.000405	CcSEcCtD
Levomilnacipran—Asthenia—Niacin—coronary artery disease	7.16e-05	0.000404	CcSEcCtD
Levomilnacipran—Fatigue—Losartan—coronary artery disease	7.16e-05	0.000404	CcSEcCtD
Levomilnacipran—Headache—Ezetimibe—coronary artery disease	7.14e-05	0.000403	CcSEcCtD
Levomilnacipran—Dry mouth—Timolol—coronary artery disease	7.1e-05	0.000401	CcSEcCtD
Levomilnacipran—Constipation—Losartan—coronary artery disease	7.1e-05	0.000401	CcSEcCtD
Levomilnacipran—Syncope—Lisinopril—coronary artery disease	7.09e-05	0.0004	CcSEcCtD
Levomilnacipran—Vomiting—Eplerenone—coronary artery disease	7.09e-05	0.0004	CcSEcCtD
Levomilnacipran—Leukopenia—Lisinopril—coronary artery disease	7.08e-05	0.0004	CcSEcCtD
Levomilnacipran—Nausea—Fenofibrate—coronary artery disease	7.07e-05	0.000399	CcSEcCtD
Levomilnacipran—Pruritus—Niacin—coronary artery disease	7.06e-05	0.000398	CcSEcCtD
Levomilnacipran—Asthenia—Pravastatin—coronary artery disease	7.05e-05	0.000398	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Furosemide—coronary artery disease	7.04e-05	0.000397	CcSEcCtD
Levomilnacipran—Rash—Eplerenone—coronary artery disease	7.03e-05	0.000397	CcSEcCtD
Levomilnacipran—Urticaria—Perindopril—coronary artery disease	7.03e-05	0.000397	CcSEcCtD
Levomilnacipran—Hypersensitivity—Trandolapril—coronary artery disease	7.03e-05	0.000397	CcSEcCtD
Levomilnacipran—Dermatitis—Eplerenone—coronary artery disease	7.03e-05	0.000397	CcSEcCtD
Levomilnacipran—Diarrhoea—Valsartan—coronary artery disease	7.02e-05	0.000396	CcSEcCtD
Levomilnacipran—Shock—Ramipril—coronary artery disease	7e-05	0.000395	CcSEcCtD
Levomilnacipran—Hypersensitivity—Enalapril—coronary artery disease	7e-05	0.000395	CcSEcCtD
Levomilnacipran—Abdominal pain—Perindopril—coronary artery disease	7e-05	0.000395	CcSEcCtD
Levomilnacipran—Body temperature increased—Perindopril—coronary artery disease	7e-05	0.000395	CcSEcCtD
Levomilnacipran—Palpitations—Lisinopril—coronary artery disease	6.99e-05	0.000394	CcSEcCtD
Levomilnacipran—Diarrhoea—Olmesartan—coronary artery disease	6.99e-05	0.000394	CcSEcCtD
Levomilnacipran—Headache—Eplerenone—coronary artery disease	6.99e-05	0.000394	CcSEcCtD
Levomilnacipran—Nervous system disorder—Ramipril—coronary artery disease	6.98e-05	0.000394	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Ramipril—coronary artery disease	6.97e-05	0.000393	CcSEcCtD
Levomilnacipran—Pruritus—Pravastatin—coronary artery disease	6.95e-05	0.000392	CcSEcCtD
Levomilnacipran—Loss of consciousness—Lisinopril—coronary artery disease	6.95e-05	0.000392	CcSEcCtD
Levomilnacipran—Nausea—Clopidogrel—coronary artery disease	6.95e-05	0.000392	CcSEcCtD
Levomilnacipran—Tachycardia—Ramipril—coronary artery disease	6.95e-05	0.000392	CcSEcCtD
Levomilnacipran—Skin disorder—Ramipril—coronary artery disease	6.92e-05	0.00039	CcSEcCtD
Levomilnacipran—Infection—Timolol—coronary artery disease	6.91e-05	0.00039	CcSEcCtD
Levomilnacipran—Vomiting—Simvastatin—coronary artery disease	6.91e-05	0.00039	CcSEcCtD
Levomilnacipran—Hypersensitivity—Telmisartan—coronary artery disease	6.91e-05	0.00039	CcSEcCtD
Levomilnacipran—Nausea—Lovastatin—coronary artery disease	6.9e-05	0.00039	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Ramipril—coronary artery disease	6.88e-05	0.000388	CcSEcCtD
Levomilnacipran—Rash—Simvastatin—coronary artery disease	6.85e-05	0.000387	CcSEcCtD
Levomilnacipran—Dermatitis—Simvastatin—coronary artery disease	6.85e-05	0.000386	CcSEcCtD
Levomilnacipran—Asthenia—Trandolapril—coronary artery disease	6.85e-05	0.000386	CcSEcCtD
Levomilnacipran—Shock—Timolol—coronary artery disease	6.85e-05	0.000386	CcSEcCtD
Levomilnacipran—Urticaria—Furosemide—coronary artery disease	6.84e-05	0.000386	CcSEcCtD
Levomilnacipran—Diarrhoea—Niacin—coronary artery disease	6.83e-05	0.000385	CcSEcCtD
Levomilnacipran—Nervous system disorder—Timolol—coronary artery disease	6.83e-05	0.000385	CcSEcCtD
Levomilnacipran—Asthenia—Enalapril—coronary artery disease	6.82e-05	0.000385	CcSEcCtD
Levomilnacipran—Headache—Simvastatin—coronary artery disease	6.81e-05	0.000384	CcSEcCtD
Levomilnacipran—Abdominal pain—Furosemide—coronary artery disease	6.8e-05	0.000384	CcSEcCtD
Levomilnacipran—Body temperature increased—Furosemide—coronary artery disease	6.8e-05	0.000384	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Losartan—coronary artery disease	6.79e-05	0.000383	CcSEcCtD
Levomilnacipran—Dizziness—Valsartan—coronary artery disease	6.79e-05	0.000383	CcSEcCtD
Levomilnacipran—Anorexia—Ramipril—coronary artery disease	6.79e-05	0.000383	CcSEcCtD
Levomilnacipran—Nausea—Ezetimibe—coronary artery disease	6.77e-05	0.000382	CcSEcCtD
Levomilnacipran—Skin disorder—Timolol—coronary artery disease	6.76e-05	0.000381	CcSEcCtD
Levomilnacipran—Dizziness—Olmesartan—coronary artery disease	6.76e-05	0.000381	CcSEcCtD
Levomilnacipran—Pruritus—Trandolapril—coronary artery disease	6.75e-05	0.000381	CcSEcCtD
Levomilnacipran—Chest pain—Lisinopril—coronary artery disease	6.74e-05	0.00038	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Timolol—coronary artery disease	6.73e-05	0.00038	CcSEcCtD
Levomilnacipran—Asthenia—Telmisartan—coronary artery disease	6.73e-05	0.00038	CcSEcCtD
Levomilnacipran—Pruritus—Enalapril—coronary artery disease	6.73e-05	0.000379	CcSEcCtD
Levomilnacipran—Diarrhoea—Pravastatin—coronary artery disease	6.72e-05	0.000379	CcSEcCtD
Levomilnacipran—Anxiety—Lisinopril—coronary artery disease	6.71e-05	0.000379	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.69e-05	0.000377	CcSEcCtD
Levomilnacipran—Hypotension—Ramipril—coronary artery disease	6.65e-05	0.000375	CcSEcCtD
Levomilnacipran—Anorexia—Timolol—coronary artery disease	6.63e-05	0.000374	CcSEcCtD
Levomilnacipran—Pruritus—Telmisartan—coronary artery disease	6.63e-05	0.000374	CcSEcCtD
Levomilnacipran—Nausea—Eplerenone—coronary artery disease	6.63e-05	0.000374	CcSEcCtD
Levomilnacipran—Dizziness—Niacin—coronary artery disease	6.6e-05	0.000372	CcSEcCtD
Levomilnacipran—Urticaria—Losartan—coronary artery disease	6.6e-05	0.000372	CcSEcCtD
Levomilnacipran—Dry mouth—Lisinopril—coronary artery disease	6.59e-05	0.000372	CcSEcCtD
Levomilnacipran—Abdominal pain—Losartan—coronary artery disease	6.56e-05	0.00037	CcSEcCtD
Levomilnacipran—Body temperature increased—Losartan—coronary artery disease	6.56e-05	0.00037	CcSEcCtD
Levomilnacipran—Asthenia—Captopril—coronary artery disease	6.54e-05	0.000369	CcSEcCtD
Levomilnacipran—Diarrhoea—Trandolapril—coronary artery disease	6.53e-05	0.000368	CcSEcCtD
Levomilnacipran—Vomiting—Valsartan—coronary artery disease	6.53e-05	0.000368	CcSEcCtD
Levomilnacipran—Diarrhoea—Enalapril—coronary artery disease	6.5e-05	0.000367	CcSEcCtD
Levomilnacipran—Hypotension—Timolol—coronary artery disease	6.5e-05	0.000367	CcSEcCtD
Levomilnacipran—Dizziness—Pravastatin—coronary artery disease	6.5e-05	0.000367	CcSEcCtD
Levomilnacipran—Vomiting—Olmesartan—coronary artery disease	6.5e-05	0.000367	CcSEcCtD
Levomilnacipran—Rash—Valsartan—coronary artery disease	6.47e-05	0.000365	CcSEcCtD
Levomilnacipran—Dermatitis—Valsartan—coronary artery disease	6.47e-05	0.000365	CcSEcCtD
Levomilnacipran—Nausea—Simvastatin—coronary artery disease	6.46e-05	0.000364	CcSEcCtD
Levomilnacipran—Pruritus—Captopril—coronary artery disease	6.45e-05	0.000364	CcSEcCtD
Levomilnacipran—Rash—Olmesartan—coronary artery disease	6.44e-05	0.000363	CcSEcCtD
Levomilnacipran—Insomnia—Ramipril—coronary artery disease	6.44e-05	0.000363	CcSEcCtD
Levomilnacipran—Dermatitis—Olmesartan—coronary artery disease	6.44e-05	0.000363	CcSEcCtD
Levomilnacipran—Headache—Valsartan—coronary artery disease	6.43e-05	0.000363	CcSEcCtD
Levomilnacipran—Diarrhoea—Telmisartan—coronary artery disease	6.42e-05	0.000362	CcSEcCtD
Levomilnacipran—Infection—Lisinopril—coronary artery disease	6.41e-05	0.000362	CcSEcCtD
Levomilnacipran—Headache—Olmesartan—coronary artery disease	6.4e-05	0.000361	CcSEcCtD
Levomilnacipran—Paraesthesia—Ramipril—coronary artery disease	6.39e-05	0.000361	CcSEcCtD
Levomilnacipran—Shock—Lisinopril—coronary artery disease	6.35e-05	0.000358	CcSEcCtD
Levomilnacipran—Asthenia—Perindopril—coronary artery disease	6.35e-05	0.000358	CcSEcCtD
Levomilnacipran—Dyspnoea—Ramipril—coronary artery disease	6.35e-05	0.000358	CcSEcCtD
Levomilnacipran—Vomiting—Niacin—coronary artery disease	6.35e-05	0.000358	CcSEcCtD
Levomilnacipran—Hypersensitivity—Furosemide—coronary artery disease	6.34e-05	0.000358	CcSEcCtD
Levomilnacipran—Somnolence—Ramipril—coronary artery disease	6.33e-05	0.000357	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Lisinopril—coronary artery disease	6.32e-05	0.000357	CcSEcCtD
Levomilnacipran—Dizziness—Trandolapril—coronary artery disease	6.31e-05	0.000356	CcSEcCtD
Levomilnacipran—Tachycardia—Lisinopril—coronary artery disease	6.3e-05	0.000356	CcSEcCtD
Levomilnacipran—Insomnia—Timolol—coronary artery disease	6.29e-05	0.000355	CcSEcCtD
Levomilnacipran—Rash—Niacin—coronary artery disease	6.29e-05	0.000355	CcSEcCtD
Levomilnacipran—Dermatitis—Niacin—coronary artery disease	6.29e-05	0.000355	CcSEcCtD
Levomilnacipran—Dizziness—Enalapril—coronary artery disease	6.29e-05	0.000355	CcSEcCtD
Levomilnacipran—Skin disorder—Lisinopril—coronary artery disease	6.27e-05	0.000354	CcSEcCtD
Levomilnacipran—Dyspepsia—Ramipril—coronary artery disease	6.27e-05	0.000354	CcSEcCtD
Levomilnacipran—Pruritus—Perindopril—coronary artery disease	6.26e-05	0.000353	CcSEcCtD
Levomilnacipran—Headache—Niacin—coronary artery disease	6.25e-05	0.000353	CcSEcCtD
Levomilnacipran—Paraesthesia—Timolol—coronary artery disease	6.25e-05	0.000353	CcSEcCtD
Levomilnacipran—Vomiting—Pravastatin—coronary artery disease	6.25e-05	0.000353	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Lisinopril—coronary artery disease	6.24e-05	0.000352	CcSEcCtD
Levomilnacipran—Diarrhoea—Captopril—coronary artery disease	6.24e-05	0.000352	CcSEcCtD
Levomilnacipran—Dyspnoea—Timolol—coronary artery disease	6.21e-05	0.00035	CcSEcCtD
Levomilnacipran—Dizziness—Telmisartan—coronary artery disease	6.2e-05	0.00035	CcSEcCtD
Levomilnacipran—Rash—Pravastatin—coronary artery disease	6.2e-05	0.00035	CcSEcCtD
Levomilnacipran—Dermatitis—Pravastatin—coronary artery disease	6.19e-05	0.000349	CcSEcCtD
Levomilnacipran—Decreased appetite—Ramipril—coronary artery disease	6.19e-05	0.000349	CcSEcCtD
Levomilnacipran—Somnolence—Timolol—coronary artery disease	6.19e-05	0.000349	CcSEcCtD
Levomilnacipran—Asthenia—Furosemide—coronary artery disease	6.17e-05	0.000348	CcSEcCtD
Levomilnacipran—Headache—Pravastatin—coronary artery disease	6.16e-05	0.000347	CcSEcCtD
Levomilnacipran—Anorexia—Lisinopril—coronary artery disease	6.15e-05	0.000347	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Ramipril—coronary artery disease	6.15e-05	0.000347	CcSEcCtD
Levomilnacipran—Fatigue—Ramipril—coronary artery disease	6.14e-05	0.000346	CcSEcCtD
Levomilnacipran—Dyspepsia—Timolol—coronary artery disease	6.13e-05	0.000346	CcSEcCtD
Levomilnacipran—Hypersensitivity—Losartan—coronary artery disease	6.12e-05	0.000345	CcSEcCtD
Levomilnacipran—Nausea—Valsartan—coronary artery disease	6.1e-05	0.000344	CcSEcCtD
Levomilnacipran—Pruritus—Furosemide—coronary artery disease	6.09e-05	0.000344	CcSEcCtD
Levomilnacipran—Constipation—Ramipril—coronary artery disease	6.09e-05	0.000343	CcSEcCtD
Levomilnacipran—Nausea—Olmesartan—coronary artery disease	6.07e-05	0.000342	CcSEcCtD
Levomilnacipran—Vomiting—Trandolapril—coronary artery disease	6.07e-05	0.000342	CcSEcCtD
Levomilnacipran—Diarrhoea—Perindopril—coronary artery disease	6.06e-05	0.000342	CcSEcCtD
Levomilnacipran—Decreased appetite—Timolol—coronary artery disease	6.05e-05	0.000341	CcSEcCtD
Levomilnacipran—Vomiting—Enalapril—coronary artery disease	6.04e-05	0.000341	CcSEcCtD
Levomilnacipran—Hypotension—Lisinopril—coronary artery disease	6.03e-05	0.00034	CcSEcCtD
Levomilnacipran—Dizziness—Captopril—coronary artery disease	6.03e-05	0.00034	CcSEcCtD
Levomilnacipran—Rash—Trandolapril—coronary artery disease	6.02e-05	0.00034	CcSEcCtD
Levomilnacipran—Dermatitis—Trandolapril—coronary artery disease	6.01e-05	0.000339	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Timolol—coronary artery disease	6.01e-05	0.000339	CcSEcCtD
Levomilnacipran—Fatigue—Timolol—coronary artery disease	6e-05	0.000339	CcSEcCtD
Levomilnacipran—Rash—Enalapril—coronary artery disease	5.99e-05	0.000338	CcSEcCtD
Levomilnacipran—Dermatitis—Enalapril—coronary artery disease	5.99e-05	0.000338	CcSEcCtD
Levomilnacipran—Headache—Trandolapril—coronary artery disease	5.98e-05	0.000337	CcSEcCtD
Levomilnacipran—Vomiting—Telmisartan—coronary artery disease	5.96e-05	0.000336	CcSEcCtD
Levomilnacipran—Asthenia—Losartan—coronary artery disease	5.96e-05	0.000336	CcSEcCtD
Levomilnacipran—Headache—Enalapril—coronary artery disease	5.96e-05	0.000336	CcSEcCtD
Levomilnacipran—Nausea—Niacin—coronary artery disease	5.93e-05	0.000335	CcSEcCtD
Levomilnacipran—Rash—Telmisartan—coronary artery disease	5.91e-05	0.000334	CcSEcCtD
Levomilnacipran—Dermatitis—Telmisartan—coronary artery disease	5.91e-05	0.000333	CcSEcCtD
Levomilnacipran—Diarrhoea—Furosemide—coronary artery disease	5.89e-05	0.000332	CcSEcCtD
Levomilnacipran—Pruritus—Losartan—coronary artery disease	5.87e-05	0.000331	CcSEcCtD
Levomilnacipran—Headache—Telmisartan—coronary artery disease	5.87e-05	0.000331	CcSEcCtD
Levomilnacipran—Dizziness—Perindopril—coronary artery disease	5.85e-05	0.00033	CcSEcCtD
Levomilnacipran—Insomnia—Lisinopril—coronary artery disease	5.84e-05	0.000329	CcSEcCtD
Levomilnacipran—Nausea—Pravastatin—coronary artery disease	5.84e-05	0.000329	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Ramipril—coronary artery disease	5.82e-05	0.000328	CcSEcCtD
Levomilnacipran—Paraesthesia—Lisinopril—coronary artery disease	5.8e-05	0.000327	CcSEcCtD
Levomilnacipran—Vomiting—Captopril—coronary artery disease	5.8e-05	0.000327	CcSEcCtD
Levomilnacipran—Dyspnoea—Lisinopril—coronary artery disease	5.76e-05	0.000325	CcSEcCtD
Levomilnacipran—Rash—Captopril—coronary artery disease	5.75e-05	0.000324	CcSEcCtD
Levomilnacipran—Dermatitis—Captopril—coronary artery disease	5.74e-05	0.000324	CcSEcCtD
Levomilnacipran—Somnolence—Lisinopril—coronary artery disease	5.74e-05	0.000324	CcSEcCtD
Levomilnacipran—Headache—Captopril—coronary artery disease	5.71e-05	0.000322	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Timolol—coronary artery disease	5.69e-05	0.000321	CcSEcCtD
Levomilnacipran—Dizziness—Furosemide—coronary artery disease	5.69e-05	0.000321	CcSEcCtD
Levomilnacipran—Dyspepsia—Lisinopril—coronary artery disease	5.68e-05	0.000321	CcSEcCtD
Levomilnacipran—Diarrhoea—Losartan—coronary artery disease	5.68e-05	0.000321	CcSEcCtD
Levomilnacipran—Nausea—Trandolapril—coronary artery disease	5.67e-05	0.00032	CcSEcCtD
Levomilnacipran—Urticaria—Ramipril—coronary artery disease	5.66e-05	0.000319	CcSEcCtD
Levomilnacipran—Nausea—Enalapril—coronary artery disease	5.65e-05	0.000319	CcSEcCtD
Levomilnacipran—Vomiting—Perindopril—coronary artery disease	5.63e-05	0.000318	CcSEcCtD
Levomilnacipran—Body temperature increased—Ramipril—coronary artery disease	5.63e-05	0.000318	CcSEcCtD
Levomilnacipran—Abdominal pain—Ramipril—coronary artery disease	5.63e-05	0.000318	CcSEcCtD
Levomilnacipran—Decreased appetite—Lisinopril—coronary artery disease	5.61e-05	0.000317	CcSEcCtD
Levomilnacipran—Rash—Perindopril—coronary artery disease	5.58e-05	0.000315	CcSEcCtD
Levomilnacipran—Dermatitis—Perindopril—coronary artery disease	5.58e-05	0.000315	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.57e-05	0.000315	CcSEcCtD
Levomilnacipran—Nausea—Telmisartan—coronary artery disease	5.57e-05	0.000314	CcSEcCtD
Levomilnacipran—Fatigue—Lisinopril—coronary artery disease	5.57e-05	0.000314	CcSEcCtD
Levomilnacipran—Headache—Perindopril—coronary artery disease	5.55e-05	0.000313	CcSEcCtD
Levomilnacipran—Urticaria—Timolol—coronary artery disease	5.53e-05	0.000312	CcSEcCtD
Levomilnacipran—Constipation—Lisinopril—coronary artery disease	5.52e-05	0.000312	CcSEcCtD
Levomilnacipran—Abdominal pain—Timolol—coronary artery disease	5.5e-05	0.00031	CcSEcCtD
Levomilnacipran—Body temperature increased—Timolol—coronary artery disease	5.5e-05	0.00031	CcSEcCtD
Levomilnacipran—Dizziness—Losartan—coronary artery disease	5.49e-05	0.00031	CcSEcCtD
Levomilnacipran—Vomiting—Furosemide—coronary artery disease	5.47e-05	0.000309	CcSEcCtD
Levomilnacipran—Rash—Furosemide—coronary artery disease	5.43e-05	0.000306	CcSEcCtD
Levomilnacipran—Dermatitis—Furosemide—coronary artery disease	5.42e-05	0.000306	CcSEcCtD
Levomilnacipran—Nausea—Captopril—coronary artery disease	5.42e-05	0.000306	CcSEcCtD
Levomilnacipran—Headache—Furosemide—coronary artery disease	5.39e-05	0.000304	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Lisinopril—coronary artery disease	5.28e-05	0.000298	CcSEcCtD
Levomilnacipran—Vomiting—Losartan—coronary artery disease	5.28e-05	0.000298	CcSEcCtD
Levomilnacipran—Nausea—Perindopril—coronary artery disease	5.26e-05	0.000297	CcSEcCtD
Levomilnacipran—Hypersensitivity—Ramipril—coronary artery disease	5.25e-05	0.000296	CcSEcCtD
Levomilnacipran—Rash—Losartan—coronary artery disease	5.24e-05	0.000295	CcSEcCtD
Levomilnacipran—Dermatitis—Losartan—coronary artery disease	5.23e-05	0.000295	CcSEcCtD
Levomilnacipran—Headache—Losartan—coronary artery disease	5.2e-05	0.000293	CcSEcCtD
Levomilnacipran—Urticaria—Lisinopril—coronary artery disease	5.13e-05	0.000289	CcSEcCtD
Levomilnacipran—Hypersensitivity—Timolol—coronary artery disease	5.13e-05	0.000289	CcSEcCtD
Levomilnacipran—Nausea—Furosemide—coronary artery disease	5.11e-05	0.000288	CcSEcCtD
Levomilnacipran—Asthenia—Ramipril—coronary artery disease	5.11e-05	0.000288	CcSEcCtD
Levomilnacipran—Body temperature increased—Lisinopril—coronary artery disease	5.1e-05	0.000288	CcSEcCtD
Levomilnacipran—Abdominal pain—Lisinopril—coronary artery disease	5.1e-05	0.000288	CcSEcCtD
Levomilnacipran—Pruritus—Ramipril—coronary artery disease	5.04e-05	0.000284	CcSEcCtD
Levomilnacipran—Asthenia—Timolol—coronary artery disease	4.99e-05	0.000282	CcSEcCtD
Levomilnacipran—Nausea—Losartan—coronary artery disease	4.93e-05	0.000278	CcSEcCtD
Levomilnacipran—Pruritus—Timolol—coronary artery disease	4.92e-05	0.000278	CcSEcCtD
Levomilnacipran—Diarrhoea—Ramipril—coronary artery disease	4.87e-05	0.000275	CcSEcCtD
Levomilnacipran—Diarrhoea—Timolol—coronary artery disease	4.76e-05	0.000269	CcSEcCtD
Levomilnacipran—Hypersensitivity—Lisinopril—coronary artery disease	4.76e-05	0.000268	CcSEcCtD
Levomilnacipran—Dizziness—Ramipril—coronary artery disease	4.71e-05	0.000266	CcSEcCtD
Levomilnacipran—Asthenia—Lisinopril—coronary artery disease	4.63e-05	0.000261	CcSEcCtD
Levomilnacipran—Dizziness—Timolol—coronary artery disease	4.6e-05	0.00026	CcSEcCtD
Levomilnacipran—Pruritus—Lisinopril—coronary artery disease	4.57e-05	0.000258	CcSEcCtD
Levomilnacipran—Vomiting—Ramipril—coronary artery disease	4.53e-05	0.000255	CcSEcCtD
Levomilnacipran—Rash—Ramipril—coronary artery disease	4.49e-05	0.000253	CcSEcCtD
Levomilnacipran—Dermatitis—Ramipril—coronary artery disease	4.48e-05	0.000253	CcSEcCtD
Levomilnacipran—Headache—Ramipril—coronary artery disease	4.46e-05	0.000252	CcSEcCtD
Levomilnacipran—Vomiting—Timolol—coronary artery disease	4.43e-05	0.00025	CcSEcCtD
Levomilnacipran—Diarrhoea—Lisinopril—coronary artery disease	4.42e-05	0.000249	CcSEcCtD
Levomilnacipran—Rash—Timolol—coronary artery disease	4.39e-05	0.000248	CcSEcCtD
Levomilnacipran—Dermatitis—Timolol—coronary artery disease	4.38e-05	0.000247	CcSEcCtD
Levomilnacipran—Headache—Timolol—coronary artery disease	4.36e-05	0.000246	CcSEcCtD
Levomilnacipran—Dizziness—Lisinopril—coronary artery disease	4.27e-05	0.000241	CcSEcCtD
Levomilnacipran—Nausea—Ramipril—coronary artery disease	4.23e-05	0.000239	CcSEcCtD
Levomilnacipran—Nausea—Timolol—coronary artery disease	4.13e-05	0.000233	CcSEcCtD
Levomilnacipran—Vomiting—Lisinopril—coronary artery disease	4.11e-05	0.000232	CcSEcCtD
Levomilnacipran—Rash—Lisinopril—coronary artery disease	4.07e-05	0.00023	CcSEcCtD
Levomilnacipran—Dermatitis—Lisinopril—coronary artery disease	4.07e-05	0.000229	CcSEcCtD
Levomilnacipran—Headache—Lisinopril—coronary artery disease	4.04e-05	0.000228	CcSEcCtD
Levomilnacipran—Nausea—Lisinopril—coronary artery disease	3.84e-05	0.000216	CcSEcCtD
Levomilnacipran—ABCB1—Metabolism—VCAN—coronary artery disease	6.11e-06	9.34e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SDC1—coronary artery disease	6.11e-06	9.34e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	6.11e-06	9.34e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDOA—coronary artery disease	6.06e-06	9.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—DCN—coronary artery disease	6.03e-06	9.22e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	6.02e-06	9.21e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.99e-06	9.15e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—DCN—coronary artery disease	5.89e-06	9e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH2—coronary artery disease	5.87e-06	8.97e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PSMA6—coronary artery disease	5.77e-06	8.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PSMB5—coronary artery disease	5.77e-06	8.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.76e-06	8.81e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—VCAN—coronary artery disease	5.76e-06	8.8e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH2—coronary artery disease	5.73e-06	8.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.72e-06	8.75e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3C2A—coronary artery disease	5.72e-06	8.74e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LIPC—coronary artery disease	5.72e-06	8.74e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HBA1—coronary artery disease	5.72e-06	8.74e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDOA—coronary artery disease	5.71e-06	8.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HK2—coronary artery disease	5.71e-06	8.73e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.71e-06	8.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOC3—coronary artery disease	5.68e-06	8.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LDLR—coronary artery disease	5.65e-06	8.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.64e-06	8.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CTGF—coronary artery disease	5.64e-06	8.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMGCR—coronary artery disease	5.59e-06	8.55e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT2—coronary artery disease	5.59e-06	8.55e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTT1—coronary artery disease	5.58e-06	8.53e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LIPC—coronary artery disease	5.58e-06	8.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC9A1—coronary artery disease	5.58e-06	8.53e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HBA1—coronary artery disease	5.58e-06	8.53e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3C2A—coronary artery disease	5.58e-06	8.53e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2C19—coronary artery disease	5.58e-06	8.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—DCN—coronary artery disease	5.55e-06	8.48e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOC3—coronary artery disease	5.55e-06	8.48e-05	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CA—coronary artery disease	5.53e-06	8.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CETP—coronary artery disease	5.52e-06	8.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GCLC—coronary artery disease	5.52e-06	8.43e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LDLR—coronary artery disease	5.51e-06	8.43e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.47e-06	8.37e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SDC1—coronary artery disease	5.45e-06	8.34e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC9A1—coronary artery disease	5.45e-06	8.33e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTT1—coronary artery disease	5.45e-06	8.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH2—coronary artery disease	5.4e-06	8.25e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CETP—coronary artery disease	5.38e-06	8.23e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GCLC—coronary artery disease	5.38e-06	8.23e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LCAT—coronary artery disease	5.37e-06	8.21e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.37e-06	8.21e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SDC1—coronary artery disease	5.32e-06	8.14e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	5.29e-06	8.08e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA4—coronary artery disease	5.27e-06	8.06e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HBA1—coronary artery disease	5.26e-06	8.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LIPC—coronary artery disease	5.26e-06	8.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2C19—coronary artery disease	5.26e-06	8.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	5.26e-06	8.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOC3—coronary artery disease	5.23e-06	7.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LDLR—coronary artery disease	5.19e-06	7.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PSMB5—coronary artery disease	5.15e-06	7.88e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PSMA6—coronary artery disease	5.15e-06	7.88e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.14e-06	7.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLCB1—coronary artery disease	5.14e-06	7.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC9A1—coronary artery disease	5.13e-06	7.85e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTT1—coronary artery disease	5.13e-06	7.85e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PDHA1—coronary artery disease	5.09e-06	7.78e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCLM—coronary artery disease	5.09e-06	7.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GCLC—coronary artery disease	5.07e-06	7.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CETP—coronary artery disease	5.07e-06	7.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.04e-06	7.71e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CTGF—coronary artery disease	5.03e-06	7.7e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PSMB5—coronary artery disease	5.03e-06	7.69e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PSMA6—coronary artery disease	5.03e-06	7.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SDC1—coronary artery disease	5.02e-06	7.67e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMGCR—coronary artery disease	4.99e-06	7.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT2—coronary artery disease	4.99e-06	7.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCA1—coronary artery disease	4.98e-06	7.62e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.93e-06	7.54e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.93e-06	7.54e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CTGF—coronary artery disease	4.91e-06	7.51e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT2—coronary artery disease	4.87e-06	7.44e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMGCR—coronary artery disease	4.87e-06	7.44e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.86e-06	7.42e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT1—coronary artery disease	4.82e-06	7.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT1—coronary artery disease	4.82e-06	7.38e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.79e-06	7.32e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HADH—coronary artery disease	4.79e-06	7.32e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	4.77e-06	7.3e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PSMA6—coronary artery disease	4.74e-06	7.25e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PSMB5—coronary artery disease	4.74e-06	7.25e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CTGF—coronary artery disease	4.63e-06	7.08e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMGCR—coronary artery disease	4.59e-06	7.02e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT2—coronary artery disease	4.59e-06	7.02e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLCB1—coronary artery disease	4.59e-06	7.01e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.54e-06	6.94e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPX2—coronary artery disease	4.54e-06	6.94e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA2—coronary artery disease	4.54e-06	6.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—coronary artery disease	4.52e-06	6.91e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.5e-06	6.88e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HK1—coronary artery disease	4.48e-06	6.85e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.48e-06	6.85e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.48e-06	6.85e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPX4—coronary artery disease	4.48e-06	6.85e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLCB1—coronary artery disease	4.48e-06	6.85e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCA1—coronary artery disease	4.45e-06	6.8e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HADHA—coronary artery disease	4.43e-06	6.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.38e-06	6.69e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCA1—coronary artery disease	4.34e-06	6.64e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTP1—coronary artery disease	4.33e-06	6.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPA—coronary artery disease	4.33e-06	6.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT1—coronary artery disease	4.31e-06	6.58e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT1—coronary artery disease	4.31e-06	6.58e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	4.29e-06	6.56e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMOX1—coronary artery disease	4.27e-06	6.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLCB1—coronary artery disease	4.22e-06	6.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAT—coronary artery disease	4.22e-06	6.45e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT1—coronary artery disease	4.2e-06	6.43e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT1—coronary artery disease	4.2e-06	6.43e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.19e-06	6.41e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA5—coronary artery disease	4.15e-06	6.34e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOB—coronary artery disease	4.09e-06	6.26e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.09e-06	6.25e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—P4HB—coronary artery disease	4.07e-06	6.22e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.99e-06	6.11e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTM1—coronary artery disease	3.98e-06	6.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT1—coronary artery disease	3.96e-06	6.06e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT1—coronary artery disease	3.96e-06	6.06e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPL—coronary artery disease	3.91e-06	5.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTP1—coronary artery disease	3.87e-06	5.91e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	3.83e-06	5.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMOX1—coronary artery disease	3.81e-06	5.83e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GPX1—coronary artery disease	3.81e-06	5.83e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTP1—coronary artery disease	3.78e-06	5.77e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—VCAN—coronary artery disease	3.76e-06	5.76e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAT—coronary artery disease	3.76e-06	5.75e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARGC1A—coronary artery disease	3.74e-06	5.72e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.74e-06	5.71e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMOX1—coronary artery disease	3.72e-06	5.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CD36—coronary artery disease	3.71e-06	5.68e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAT—coronary artery disease	3.67e-06	5.62e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPP2CA—coronary artery disease	3.67e-06	5.61e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOB—coronary artery disease	3.65e-06	5.59e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DCN—coronary artery disease	3.63e-06	5.55e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOB—coronary artery disease	3.57e-06	5.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTP1—coronary artery disease	3.56e-06	5.44e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTM1—coronary artery disease	3.55e-06	5.43e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.53e-06	5.39e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	3.52e-06	5.39e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MTHFR—coronary artery disease	3.52e-06	5.38e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMOX1—coronary artery disease	3.51e-06	5.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPL—coronary artery disease	3.49e-06	5.33e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTM1—coronary artery disease	3.47e-06	5.3e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAT—coronary artery disease	3.46e-06	5.29e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LIPC—coronary artery disease	3.44e-06	5.26e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HBA1—coronary artery disease	3.44e-06	5.26e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.44e-06	5.26e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.44e-06	5.26e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOC3—coronary artery disease	3.42e-06	5.22e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPL—coronary artery disease	3.41e-06	5.21e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GPX1—coronary artery disease	3.4e-06	5.2e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LDLR—coronary artery disease	3.4e-06	5.19e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOB—coronary artery disease	3.36e-06	5.14e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.36e-06	5.13e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.36e-06	5.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AGT—coronary artery disease	3.34e-06	5.11e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GPX1—coronary artery disease	3.32e-06	5.08e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GCLC—coronary artery disease	3.32e-06	5.07e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CETP—coronary artery disease	3.32e-06	5.07e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CD36—coronary artery disease	3.31e-06	5.07e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SDC1—coronary artery disease	3.28e-06	5.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOE—coronary artery disease	3.28e-06	5.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPP2CA—coronary artery disease	3.27e-06	5.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.27e-06	5e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOA1—coronary artery disease	3.24e-06	4.95e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CD36—coronary artery disease	3.24e-06	4.95e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPL—coronary artery disease	3.21e-06	4.91e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.2e-06	4.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTHFR—coronary artery disease	3.14e-06	4.8e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GPX1—coronary artery disease	3.13e-06	4.79e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.1e-06	4.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.1e-06	4.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.1e-06	4.74e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTHFR—coronary artery disease	3.07e-06	4.69e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CD36—coronary artery disease	3.05e-06	4.66e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CTGF—coronary artery disease	3.03e-06	4.63e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.01e-06	4.6e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMGCR—coronary artery disease	3e-06	4.59e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT2—coronary artery disease	3e-06	4.59e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AGT—coronary artery disease	2.98e-06	4.56e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOE—coronary artery disease	2.92e-06	4.47e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AGT—coronary artery disease	2.91e-06	4.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOA1—coronary artery disease	2.89e-06	4.42e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTHFR—coronary artery disease	2.89e-06	4.42e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOE—coronary artery disease	2.85e-06	4.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—coronary artery disease	2.85e-06	4.36e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOA1—coronary artery disease	2.82e-06	4.31e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—coronary artery disease	2.81e-06	4.3e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.77e-06	4.23e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.76e-06	4.22e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AGT—coronary artery disease	2.75e-06	4.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOE—coronary artery disease	2.69e-06	4.11e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.67e-06	4.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOA1—coronary artery disease	2.66e-06	4.07e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT1—coronary artery disease	2.59e-06	3.96e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT1—coronary artery disease	2.59e-06	3.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—coronary artery disease	2.57e-06	3.92e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—coronary artery disease	2.55e-06	3.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—coronary artery disease	2.51e-06	3.84e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—coronary artery disease	2.49e-06	3.8e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NOS3—coronary artery disease	2.45e-06	3.75e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—coronary artery disease	2.45e-06	3.75e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—coronary artery disease	2.34e-06	3.58e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.33e-06	3.56e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—coronary artery disease	2.31e-06	3.53e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.3e-06	3.52e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.29e-06	3.51e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—coronary artery disease	2.29e-06	3.5e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAT—coronary artery disease	2.26e-06	3.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—coronary artery disease	2.24e-06	3.43e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—coronary artery disease	2.24e-06	3.42e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOB—coronary artery disease	2.2e-06	3.36e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NOS3—coronary artery disease	2.19e-06	3.35e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NOS3—coronary artery disease	2.14e-06	3.27e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.14e-06	3.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—coronary artery disease	2.11e-06	3.22e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPL—coronary artery disease	2.1e-06	3.21e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPX1—coronary artery disease	2.05e-06	3.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NOS3—coronary artery disease	2.02e-06	3.08e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—coronary artery disease	2e-06	3.06e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CD36—coronary artery disease	1.99e-06	3.05e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.97e-06	3.01e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—coronary artery disease	1.96e-06	2.99e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.89e-06	2.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.84e-06	2.82e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AGT—coronary artery disease	1.79e-06	2.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOE—coronary artery disease	1.76e-06	2.69e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOA1—coronary artery disease	1.74e-06	2.66e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—coronary artery disease	1.53e-06	2.34e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—coronary artery disease	1.51e-06	2.31e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CA—coronary artery disease	1.38e-06	2.11e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—coronary artery disease	1.38e-06	2.11e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NOS3—coronary artery disease	1.32e-06	2.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.23e-06	1.88e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.2e-06	1.84e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.2e-06	1.84e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.13e-06	1.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—coronary artery disease	1.13e-06	1.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—coronary artery disease	1.01e-06	1.54e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—coronary artery disease	9.83e-07	1.5e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—coronary artery disease	9.26e-07	1.42e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CA—coronary artery disease	7.41e-07	1.13e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—coronary artery disease	6.06e-07	9.26e-06	CbGpPWpGaD
